ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Risk assessment on change of testing requirements for partner donation of reproductive cells
In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.
Joint ECDC-EFSA rapid outbreak assessment: Outbreak of hepatitis A virus infection in residents and travellers to Italy
Since 1 January 2013 there have been 15 laboratory-confirmed cases of hepatitis A (HAV) infection reported in Germany, the Netherlands and Poland. All cases had travelled to the provinces of Trento and Bolzano in northern Italy during the exposure period.
Outbreak of hepatitis A virus infection in travellers returning from Egypt
Between 1 November 2012 and 30 April 2013, 15 confirmed cases of hepatitis A virus infections with subgenotype IB and identical RNA sequence, and 89 probable cases, have been reported in 14 EU/EFTA countries. All cases have a travel history to Egypt.
Joint ECDC-EFSA assessment - Outbreak of hepatitis A virus infection in four Nordic countries
Between 1 October 2012 and 8 April 2013, 16 confirmed cases of hepatitis A virus (HAV) infections with subgenotype IB and identical RNA sequence were reported in four Nordic countries.
Rapid Outbreak Assessment: Update: Outbreak of hepatitis A virus infection in Italy and Ireland
Since publishing the ’Joint ECDC-EFSA rapid outbreak assessment: Outbreak of hepatitis A virus infection in residents and travellers to Italy’ in May, new information has emerged as a result of the epidemiological, microbiological and environmental investigations. Therefore, ECDC has updated its previous assessment.
Rapid Outbreak Assessment: Outbreak of hepatitis A in EU/EEA countries
Updated joint Rapid Outbreak Assessment with EFSA on the current outbreak of hepatitis A in EU/EEA countries.
Public health guidance on HIV and STI prevention among men who have sex with men
This guidance, based on a systematic review of the literature and expert opinion, suggests that there is good evidence to ensure that some key components are considered for inclusion in national and sub-national public health programmes in countries in Europe.
Systematic review on hepatitis B and C prevalence in the EU/EEA
ECDC conducted a systematic review of the literature published between 2005–2015, with the aim to estimate the prevalence of hepatitis B and C in the general population and specific population subgroups in the EU/EEA Member States. This review is an update of an earlier review covering the period 2000–2009.